Patents by Inventor Joseph W. Boyd

Joseph W. Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds useful for the treatment of conditions associated with weight gain
    Patent number: 8093248
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: January 10, 2012
    Assignee: AstraZeneca AB (PUBL)
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom, Viet-Anh Anne Horgan (Nee Nguyen), Jaqueline Ouzman, Iain Simpson
  • PIPERAZINES AS ANTI-OBESITY AGENTS
    Publication number: 20110059969
    Abstract: The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds, to processes for their preparation, and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Application
    Filed: December 5, 2008
    Publication date: March 10, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom
  • NEW COMPOUNDS I
    Publication number: 20110046135
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Application
    Filed: November 1, 2010
    Publication date: February 24, 2011
    Applicant: ASTRAZENECA AB (PUBL)
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom
  • Compounds I
    Patent number: 7851471
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: December 14, 2010
    Assignee: AstraZeneca AB (PUBL)
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom
  • Compounds II
    Publication number: 20090281087
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Application
    Filed: December 5, 2008
    Publication date: November 12, 2009
    Applicant: Biovitrum AB
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom, Viet-Anh Anne Horgan (nee Nguyen), Jaqueline Ouzman, Iain Simpson
  • New compounds I
    Publication number: 20090181967
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Application
    Filed: December 5, 2008
    Publication date: July 16, 2009
    Applicant: Biovitrum AB
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom
  • New compounds III
    Publication number: 20090176798
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Application
    Filed: December 5, 2008
    Publication date: July 9, 2009
    Applicant: Biovitrum AB
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom